Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 437, 141-146 (1 September 2005) | doi:10.1038/nature03954; Received 7 February 2005; Accepted 23 June 2005
Open Innovation Challenges
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
nature jobs
BBSRC Industrial CASE Studentship
- University College London
- London WC1E 6JF United Kingdom
Director, UQ Centre for Clinical Research
- University of Queensland, Brisbane, Australia
- Brisbane, Queensland, Australia
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
Gerald Willimsky1 & Thomas Blankenstein1,2
- Institute of Immunology, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
- Max Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13122 Berlin, Germany
Correspondence to: Thomas Blankenstein1,2 Correspondence and requests for materials should be addressed to T.B. (Email: tblanke@mdc-berlin.de).
Abstract
The recognition and elimination of tumours by T cells, a process termed cancer immunosurveillance1, is effective against certain virus-associated cancers2. Spontaneous tumours often induce a specific immune response and are therefore also immunogenic. However, it is not clear whether they can be controlled by T cells3, 4, 5, 6, 7, 8, 9, 10. The immunosurveillance hypothesis postulates that tumours, if they eventually grow, escaped T-cell recognition by losing immunogenicity6, 7, 8. Here we show, by generating a mouse model of sporadic cancer based on rare spontaneous activation of a dormant oncogene, that immunogenic tumours do not escape their recognition but induce tolerance. In this model, tumours derive from single cells and express a tumour-specific transplantation rejection antigen. Whereas vaccinated mice remain tumour-free throughout their lifetime, naive mice always develop a progressively growing tumour. We also show that despite specific recognition by T cells, the tumours do not lose their intrinsic immunogenicity and are rejected after transplantation in T-cell-competent recipients. Furthermore, in the primary host tumour-induced tolerance is associated with the expansion of non-functional T cells. Together, our data argue against immunosurveillance of spontaneous cancer.
- Institute of Immunology, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
- Max Delbrück Center for Molecular Medicine, Robert-Roessle Strasse 10, 13122 Berlin, Germany
Correspondence to: Thomas Blankenstein1,2 Correspondence and requests for materials should be addressed to T.B. (Email: tblanke@mdc-berlin.de).
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
A test of the role of the proximal histidines in the Perutz model for cooperativity in haemoglobinNature Structural Biology Article (01 Jan 1997)
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transferNature Immunology Article (01 Oct 2001)
Sustained somatic gene inactivation by viral transfer of Cre recombinaseNature Biotechnology Research Article (01 Nov 1996)

